Product Information

BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.7734 per EA under NDC 00054300001. Its NADAC has been published 233 times since Jun 1, 2022.

FDA first approved this application on Jan 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP

Butalbital, Acetaminophen, Caffeine and Codeine Phosphate
$0.7734per EA
DEA Schedule CIII

Strength

325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1

NDC

00054300001

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215138

FDA Approved

1/26/2022

TE Code

AB

On Market Since

5/9/2022

Pharmacological Classes

Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Full Opioid Agonists
Methylxanthine
Opioid Agonist
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has been published 233 times since Jun 1, 2022, and over the history we have for it it has declined 10.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7734 per EA
All-time high$0.9542 (Feb 15, 2023)
All-time low$0.5885 (Nov 20, 2024)
52-week high$0.9086
52-week low$0.7734
Median price$0.8537
Average price$0.8440
Largest weekly change+43.5% (Jul 20, 2022)
Weeks tracked233
Tracking sinceJun 1, 2022

Price History

1W

0.0%

1M

-3.1%

3M

-3.2%

6M

-9.2%

1Y

-13.9%

3Y

-9.4%

5Y

N/A

All

-10.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.7734 per EA (NDC 00054300001), effective Nov 11, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has declined 10.0%. It has been tracked across 233 weekly CMS publications since Jun 1, 2022.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?

Since Jun 1, 2022, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has ranged from a low of $0.5885 (Nov 20, 2024) to a high of $0.9542 (Feb 15, 2023), with a median of $0.8537 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP in a comparable dosage form, but none are currently priced below it.

Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?

BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP (NDC 00054300001) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.